According to the Financial Times, British pharmaceutical company AstraZeneca has been exploring a merger with its American rival Bristol Myers Squibb, which would create one of the world's largest pharmaceutical groups with a market value of nearly $400 billion. Sources familiar with the matter revealed that the two companies have been in merger talks for several months and may reach an agreement in the near future, though negotiations could also be delayed or fall through. AstraZeneca is the s

According to the Financial Times, British pharmaceutical company AstraZeneca has been exploring a merger deal with its US competitor Bristol Myers Squibb. After the merger, this would create one of the largest pharmaceutical groups in the world, with a market value of nearly $400 billion. Sources familiar with the matter revealed that the two companies have been discussing the merger for several months, and an agreement could be reached soon, though it may also be delayed or fall through. AstraZeneca is the second most valuable listed company in the UK, with a market value of about £196 billion, while Bristol Myers Squibb’s market value is roughly $133 billion. If the deal is completed, it would become one of the largest corporate mergers in history. This transaction would further accelerate the British pharmaceutical giant’s strategic shift toward the US market.